Atherosclerosis in haemodialysis patients without significant comorbidities: Determinants of progression

Aim: The aim of this prospective study was to assess the determinants of the progression of carotid artery intima‐media thickness (CA‐IMT) for 1 year in haemodialysis (HD) patients without significant comorbidities. Methods: Fifty‐four HD patients younger than 55 years, without diabetes, obesity and any clinical evidence of cardiovascular disease (29 men, 25 women; mean age 33.3 ± 10 years; mean time on HD 49.4 ± 43 months) were included in the 1‐year study. CA‐IMT was assessed at baseline and after 12 months. The difference in IMT between these two points of time was calculated (ΔCA‐IMT). C‐reactive protein (CRP), erythrocyte sedimentation rate (ESR), haematocrit‐corrected ESR, beta‐2 microglobulin, cardiac troponin I, lipid profile, fibrinogen, homocysteine, CaXP product, intact parathyroid hormone, haematocrit, albumin, uric acid levels, anthropometric parameters (age, body mass index), smoking, hypertension and left ventricular hypertrophy were recorded at baseline. Results: The mean value for CA‐IMT at baseline (0.59 ± 0.05 mm) was significantly lower than that at 12 months (0.64 ± 0.07 mm) (P